Literature DB >> 9849812

Influence of age and sex on serum concentrations of total dimeric activin A.

P Loria1, F Petraglia, M Concari, M Bertolotti, P Martella, S Luisi, C Grisolia, C Foresta, A Volpe, A R Genazzani, N Carulli.   

Abstract

Several studies have shown that activin A is secreted in substantial amounts into the systemic circulation. The changes that occur during menstrual cycle and pregnancy suggest a correlation with reproductive function. At present, however, no definitive evidence has confirmed this pattern throughout adult life; moreover, neither the origin nor the physiological implications of this circulating growth factor have been clearly defined. The aim of the present study was to evaluate whether circulating concentrations of activin A change in adult men and women according to age and sex, and to examine the possible correlation with serum concentrations of FSH. Total dimeric activin A was measured using a specific two-site enzyme immunoassay in serum specimens collected from a cohort of normal individuals enrolled in an epidemiological survey. A group of men (n = 106) and one of women (n=151) were subdivided into six age groups (20-30, 30-40, 40-50, 50-60, 60-70 and 70-90 years). In a small group of 8 men and 11 women, serum concentrations of activin A were evaluated twice, in specimens collected at an interval of 10 years. Serum FSH concentrations were also measured in all specimens. Serum concentrations of activin A were not significantly different in men and women and showed an age-related progressive increase between 20 and 50 years of age (P<0.01, those aged 40-50 compared with those aged 20-30 years). After the age of 50 years, activin A concentrations remained in the same range of values in women, whereas they increased significantly in men, reaching peak values between 70 and 90 years (P<0.01 compared with the group aged between 20 and 50 years). From the age of 50 years, activin A concentrations were significantly greater in men compared with those in women in the corresponding age groups (P<0.001). Activin A concentrations correlated with age in men, but not in women. No significant correlation between concentrations of activin A and FSH was found in either sex. Activin A concentrations in specimens collected 10 years apart showed an increase in seven of eight men, but not in women. Finally, no significant variations of activin A concentrations were observed when fertile and postmenopausal women were compared. The present data indicate that circulating concentrations of activin A vary according to age; furthermore, men older than 50 years have greater concentrations than women. These changes, which occur irrespectively of FSH concentrations, indicate that circulating activin A is not a hormone of the reproductive axis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9849812     DOI: 10.1530/eje.0.1390487

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  11 in total

1.  Differential effects of aging on activin A and its binding protein, follistatin, across the menopause transition.

Authors:  Nancy E Reame; Jane L Lukacs; Pamela Olton; Rudi Ansbacher; Vasantha Padmanabhan
Journal:  Fertil Steril       Date:  2007-04-16       Impact factor: 7.329

2.  Regulation of muscle mass by follistatin and activins.

Authors:  Se-Jin Lee; Yun-Sil Lee; Teresa A Zimmers; Arshia Soleimani; Martin M Matzuk; Kunihiro Tsuchida; Ronald D Cohn; Elisabeth R Barton
Journal:  Mol Endocrinol       Date:  2010-09-01

3.  Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases.

Authors:  B D Chang; K Watanabe; E V Broude; J Fang; J C Poole; T V Kalinichenko; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

4.  Serum activin A and B levels predict outcome in patients with acute respiratory failure: a prospective cohort study.

Authors:  David Morritz de Kretser; Jonathan Guy Bensley; Ville Pettilä; Rita Linko; Mark Peter Hedger; Susan Hayward; Carolyn Anne Allan; Robert Ian McLachlan; Helen Ludlow; David James Phillips
Journal:  Crit Care       Date:  2013-10-31       Impact factor: 9.097

5.  Activin A more prominently regulates muscle mass in primates than does GDF8.

Authors:  Esther Latres; Jason Mastaitis; Wen Fury; Lawrence Miloscio; Jesus Trejos; Jeffrey Pangilinan; Haruka Okamoto; Katie Cavino; Erqian Na; Angelos Papatheodorou; Tobias Willer; Yu Bai; Jee Hae Kim; Ashique Rafique; Stephen Jaspers; Trevor Stitt; Andrew J Murphy; George D Yancopoulos; Jesper Gromada
Journal:  Nat Commun       Date:  2017-04-28       Impact factor: 14.919

Review 6.  Hormone Replacement Therapy: Would it be Possible to Replicate a Functional Ovary?

Authors:  Swati Agarwal; Faisal A Alzahrani; Asif Ahmed
Journal:  Int J Mol Sci       Date:  2018-10-14       Impact factor: 5.923

7.  Activin subfamily peptides predict chronological age in humans.

Authors:  Lady V Barrios-Silva; Mack Parnell; Zahida B Shinwari; Ghulam A Chaudhary; Thanasis Xenofontos; Angel van Bekhoven; Simon McArthur; Bradley T Elliott
Journal:  Physiol Rep       Date:  2018-09

8.  Circadian rhythm of activin A and related parameters of mineral metabolism in normal and uremic rats.

Authors:  Anders Nordholm; Søren Egstrand; Eva Gravesen; Maria L Mace; Marya Morevati; Klaus Olgaard; Ewa Lewin
Journal:  Pflugers Arch       Date:  2019-06-24       Impact factor: 3.657

9.  Effects of elastic band resistance training and nutritional supplementation on muscle quality and circulating muscle growth and degradation factors of institutionalized elderly women: the Vienna Active Ageing Study (VAAS).

Authors:  Marlene Hofmann; Barbara Schober-Halper; Stefan Oesen; Bernhard Franzke; Harald Tschan; Norbert Bachl; Eva-Maria Strasser; Michael Quittan; Karl-Heinz Wagner; Barbara Wessner
Journal:  Eur J Appl Physiol       Date:  2016-03-01       Impact factor: 3.078

Review 10.  Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.

Authors:  Toshifumi Sugatani
Journal:  Int J Mol Sci       Date:  2018-08-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.